RIPK1 and Alzheimer disease: RIPK1 expression is markedly elevated in advanced AD (higher Braak stages), correlating with reduced brain weight and suggesting a pivotal role in AD-associated neurodegeneration (Caccamo et al., 2017) see Figure 4.